Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review

Small-cell lung cancer (SCLC) transformation from EGFR mutant adenocarcinoma is a rare entity that is considered to be a new phenotype of SCLC. While transformation from adenocarcinoma (ADC) with EGFR exon 19 deletions and exon 21 L858R point mutations has been described, to our knowledge, no cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Digiacomo, Nunzio, De Pas, Tommaso, Rossi, Giovanna, Bossi, Paola, Stucchi, Erika, Conforti, Fabio, Cocorocchio, Emilia, Laszlo, Daniele, Pala, Laura, Zattarin, Emma, Catania, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047844/
https://www.ncbi.nlm.nih.gov/pubmed/36975478
http://dx.doi.org/10.3390/curroncol30030265
Descripción
Sumario:Small-cell lung cancer (SCLC) transformation from EGFR mutant adenocarcinoma is a rare entity that is considered to be a new phenotype of SCLC. While transformation from adenocarcinoma (ADC) with EGFR exon 19 deletions and exon 21 L858R point mutations has been described, to our knowledge, no cases of transformation to SCLC from exon-18-mutated ADC have been reported. We reported a clinical case of a patient with exon-18-EGFR-transformed SCLC, and we performed a systematic review of the literature.

Ejemplares similares